COMBINED CRITICAL ILLNESS–RELATED CORTICOSTEROID AND THYROID INSUFFICIENCY DURING TARGETED TEMPERATURE MANAGEMENT: A PROSPECTIVE COHORT STUDY

Objective. To study the effect of therapy for adrenal and thyroid dysfunction on the course and outcomes of critical care.

Materials and methods. 51 patients requiring targeted temperature management (ТТМ) were included in a single-center prospective cohort study.

Results. Group I (with adrenal and thyroid dysfunction) included 39 (76,5%) patients on TTM, group II (without adrenal and thyroid dysfunction ) included 12 (23,5%) patients without endocrinopathies. In patients on TTM, adrenal dysfunction developed on day (D) 0 and manifested only clinically in the form of vascular insufficiency. When evaluating clinical and laboratory data in patients at TTM, thyroid dysfunction was diagnosed at D1, D2, and D3. The manifestation of adrenal and thyroid dysfunction in patients at is primarily due to central nervous system injury rather than sepsis. Treatment of adrenal and thyroid dysfunction was performed with hydrocortisone and levothyroxine.

Conclusion. Formation of combination of adrenal and thyroid dysfunction at TTM leads to the development of multiple organ dysfunction not associated with the development of septic complications. Timely diagnosis and adequate correction of adrenal and thyroid dysfunction in patients undergoing critical illness and requiring TTM allows to reliably reduce mortality.

1. Ganesan K., Anastasopoulou C., Wadud K. Euthyroid Sick Syndrome. 2022 Dec 8. In: StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing. 2024 Jan.

2. Mourouzis I.; Apostolaki V.; Trikas A.; Kokkinos L.; Alexandrou N.; Avdikou M.; Giannoulopoulou M.; Vassi A.; Tseti I.; Pantos C. The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence. Int. J. Environ. Res. Public Health 2022. 19. 8063. https://doi.org/10.3390/ijerph19138063.

3. Saha D., Chattopadhyay S., Dutta S.S., Roy A.K. Critically ill patients: Histopathological evidence of thyroid dysfunction. J Crit Care. 2023. 78. 154384. doi:10.1016/j.jcrc.2023.154384.

4. Dankiewicz J., Cronberg T., Lilja, G. et al. Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2). A randomized clinical trial. Rationale and design. American Heart Journal. 2019. Jun: 23–31. doi: 10.1016/j.ahj.2019.06.012.

5. Tripathy S., Mahapatra A.K. Targeted temperature management in brain protection: An evidence-based review. Indian J Anaesth. 2015. 59 (1). 9-14. doi: 10.4103/0019-5049.149442.

6. Scaramuzzo R.T., Giampietri M., Fiorentini E., et al. Serum cortisol concentrations during induced hypothermia for perinatal asphyxia are associated with neurological outcome in human infants. Stress. 2014. 18 (1). 129-133. doi.org/10.3109/10253890.2014.987120.

7. de Jong M.F., Beishuizen A., de Jong M.J., et al. The pituitary-adrenal axis is activated more in nonsurvivors than in survivors of cardiac arrest, irrespective of therapeutic hypothermia. Resuscitation. 2008 Sep. 78 (3). 281. doi: 10.1016/j.resuscitation.2008.03.227.

8. Jagt van der M., Knoops S., Jong de M.F. et al. Increased thyroxin during therapeutic hypothermia predicts death in comatose patients after cardiac arrest. Neurocrit care. 2015. 23 (2). 198–204. doi.org/10.1007/s12028-014-0091-8.

9. Iltumur K., Olmez G., Ariturk Z. et al. Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome. Crit Care. 2005. 9. 416-424. doi.org/10.1186/cc3727.

10. Meissner W., Krapp C., Kauf E., et al. Thyroid hormone response to moderate hypothermia in severe brain injury. Intensive Care Med. 2003. 29. 44-48. doi.org/10.1007/s00134-002-1556-3.

11. Ranasinghe A.M., Bonser R.S. Endocrine changes in brain death and transplantation. Best Pract Res Clin Endocrinol Metab. 2011. 25. 799-812. doi.org/10.1016/j.beem.2011.03.003.

12. Arcellana A.E., Lim K.W., Arcegono M., Jimeno C. The Development of a Protocol for Critical IllnessRelated Corticosteroid Insufficiency (CIRCI) at a Tertiary Hospital. J ASEAN Fed Endocr Soc. 2022. 37 (1). 14-23. doi.10.15605/jafes.037.01.03.

13. Evans L., Rhodes A., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021. 47 (11). 1181–1247. doi.org/10.1007/s00134-021-06506-y.

14. Potapov A.A., Krylov V.V., Gavrilov A.G., Kravchuk A.D., Likhterman L.B., Petrikov S.S., Talypov A.E., Zakharova N.E., Oshorov A.V., Solodov A.A. Guidelines for the management of severe head injury. Part 1. Neurotrauma system and neuroimaging. Burdenko's Journal of Neurosurgery. 2015. 79 (6). 100-106. https://doi.org/10.17116/neiro2015796100-106. in Russian.

15. Beck-Peccoz P., Rodari G., Giavoli C., Lania A. Central hypothyroidism - a neglected thyroid disorder. Nat Rev Endocrinol. 2017. 13 (10). 588–598. doi: 10.1038/nrendo.2017.47.

16. Vinagre A.L, Souza M.V. Levothyroxine absorption and difficult management of hypothyroid patients in the intensive care unit: two case reports and a literature review. Interferências na absorção de levotiroxina e dificuldades no manuseio de pacientes com hipotireoidismo na unidade de terapia intensiva: relato de dois casos e revisão de literatura. Rev Bras Ter Intensiva. 2011. 23 (2). 242-248. PMID: 25299727.

17. Petunina N.A., Trukhina L.V., Martirosian N.S. Central hypothyroidism: modern conceps in diagnostics and treatment. Therapeutic Archive. 2019. 91 (10). 135–138. DOI: 10.26442/00403660.2019.10.000358 . in Russian.

18. Altshuler N.E., Kutsyi M.B., Kruglyakov N.M. et al. Adrenal dysfunction and its correction during extracorporeal membrane oxygenation: a prospective cohort study. Transbaikal Medical Bulletin. 2023. 2. 1-19. DOI 10.52485/19986173_2023_2_1.